Free tool
FAERS Monitor: Byetta
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021773 or its brand name (Byetta, Exenatide Synthetic). Reports on generic versions are filed under their own applications.
Reports
52,320
Serious
14,635
28% of reports
Hospitalization
7,538
Death reported
1,764
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- blood glucose increased15,472
- weight decreased12,126
- nausea12,042
- decreased appetite5,643
- blood glucose decreased5,516
- vomiting4,346
- diarrhoea2,742
- dizziness2,674
- drug ineffective2,251
- headache2,087
- injection site pain2,023
- pancreatitis2,011
- injection site bruising1,843
- injection site haemorrhage1,810
- fatigue1,760
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 1,970 |
| 2006 | 12,666 |
| 2007 | 12,432 |
| 2008 | 7,681 |
| 2009 | 2,461 |
| 2010 | 1,753 |
| 2011 | 1,820 |
| 2012 | 996 |
| 2013 | 1,460 |
| 2014 | 1,912 |
| 2015 | 2,516 |
| 2016 | 1,149 |
| 2017 | 892 |
| 2018 | 771 |
| 2019 | 642 |
| 2020 | 340 |
| 2021 | 274 |
| 2022 | 197 |
| 2023 | 127 |
| 2024 | 169 |
| 2025 | 75 |
| 2026 | 17 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,001,839 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| blood glucose decreasedSignal | 5,516 | 52.0 | 50.7 | 244,923 |
| blood glucose increasedSignal | 15,472 | 35.9 | 35.4 | 485,806 |
| weight decreasedSignal | 12,126 | 18.2 | 17.9 | 191,174 |
| pancreatitisSignal | 2,011 | 15.9 | 15.2 | 26,994 |
| decreased appetiteSignal | 5,643 | 10.0 | 9.7 | 45,005 |
| injection site bruisingSignal | 1,843 | 9.5 | 9.1 | 13,706 |
| injection site haemorrhageSignal | 1,810 | 9.3 | 8.9 | 13,143 |
| nauseaSignal | 12,042 | 6.2 | 6.1 | 53,683 |
| vomitingSignal | 4,346 | 3.7 | 3.6 | 8,843 |
| injection site painSignal | 2,023 | 2.7 | 2.6 | 2,115 |
| dizzinessSignal | 2,674 | 2.2 | 2.1 | 1,699 |
| diarrhoea | 2,742 | 1.7 | 1.6 | 831 |
| headache | 2,087 | 1.3 | 1.3 | 184 |
| fatigue | 1,760 | 0.9 | 0.9 | 17 |
| drug ineffective | 2,251 | 0.7 | 0.7 | 344 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.